CohBar

About:

CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.

Website: http://cohbar.com

Description:

CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using cell-based assays and animal models of disease, to rapidly identify naturally occurring MDPs with promising biological activity. The company was founded in 2007 and is headquartered in Menlo Park, California.

Total Funding Amount:

$39.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)cohbar.com

Founders:

David Sinclair, John Amatruda, Laura J. Cobb, Nir Barzilai, Pinchas Cohen

Number of Employees:

1-10

Last Funding Date:

2021-10-28

IPO Status:

Public

Industries: